GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the botulinum neurotoxin serotype G binding domain

Analyse Crystal structure of the botulinum neurotoxin serotype G binding domain in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2VXR
Type
protein
Length
428 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type G
UniProt
Q60393
Ligands
SO4
Pockets
3 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type Gprotein4287% helix, 45% strandQ60393

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 3 copies · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11720.550.8024empty
2890.490.8224empty
3910.320.7319empty

Compared structures

  • 2VXR · Crystal Structure of the Botulinum Neurotoxin serotype G binding domain · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.